Velarion Records
Free. Unsubscribe any time.

Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics, Inc. filed 45 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 68 transactions and 677,386 shares. None carries the SEC's AFF10B5ONE flag; all 45 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Arcutis Biotherapeutics, Inc. 68

Adoption dates in Arcutis Biotherapeutics, Inc. 11

Results prints in Arcutis Biotherapeutics, Inc. 7

Trades before a print in Arcutis Biotherapeutics, Inc. 4

Interval to Arcutis Biotherapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Arcutis Biotherapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on March 11, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.